Use of aromatase inhibitors in practice of gynecology

13Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Purpose: The conversion of androgens into estrogens by aromatase is called aromatization and is inhibited by aromatase inhibitors (AIs). The aim of this article is to evaluate the use of aromatase inhibitors in gynecological diseases such as endometriosis, leiomyoma, estrogen- dependent gynecologic neoplasia and infertility. Methods: This is a review of literature combined with experience and use of aromatase inhibitors in practice of gynecology. Conclusion: AIs are promising agents in treatment of estrogen dependent disease. However lack of experience, side effects and cost are limiting factors for using these agents in infertility treatment. However there is need for larger, well designed randomized trials to generate robust data in order to establish the true potential of aromatase inhibitors.

Cite

CITATION STYLE

APA

Usluogullari, B., Duvan, C. Z., & Usluogullari, C. A. (2015, February 25). Use of aromatase inhibitors in practice of gynecology. Journal of Ovarian Research. BioMed Central Ltd. https://doi.org/10.1186/s13048-015-0131-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free